Publications in collaboration with researchers from Hospital Universitario de Salamanca (18)

2024

  1. Novel risk loci for COVID-19 hospitalization among admixed American populations

    eLife, Vol. 13

  2. Preclinical validation of human recombinant glutamate-oxaloacetate transaminase for the treatment of acute ischemic stroke

    iScience, Vol. 27, Núm. 11

2023

  1. A second update on mapping the human genetic architecture of COVID-19

    Nature

2022

  1. Novel genes and sex differences in COVID-19 severity

    Human molecular genetics, Vol. 31, Núm. 22, pp. 3789-3806

2021

  1. Food groups associated with immune-mediated inflammatory diseases: a Mendelian randomization and disease severity study

    European Journal of Clinical Nutrition, Vol. 75, Núm. 9, pp. 1368-1382

2020

  1. Nuclear WRAP53 promotes neuronal survival and functional recovery after stroke

    Science advances, Vol. 6, Núm. 41

2019

  1. Genetic variation at the glycosaminoglycan metabolism pathway contributes to the risk of psoriatic arthritis but not psoriasis

    Annals of the Rheumatic Diseases, Vol. 78, Núm. 3, pp. 355-364

2018

  1. Single-nucleotide polymorphism 309T>G in the MDM2 promoter determines functional outcome after stroke

    Stroke, Vol. 49, Núm. 10, pp. 2437-2444

2017

  1. Neovascularization and functional recovery after intracerebral hemorrhage is conditioned by the Tp53 Arg72Pro single-nucleotide polymorphism

    Cell Death and Differentiation, Vol. 24, Núm. 1, pp. 144-154

2015

  1. Association between SNPs of metalloproteinases and prostaglandin f2α receptor genes and latanoprost response in open-angle glaucoma

    Ophthalmology, Vol. 122, Núm. 5, pp. 1040-1048.e4

  2. Study of Protein Expresion in Peri-Infarct Tissue after Cerebral Ischemia

    Scientific Reports, Vol. 5

2014

  1. In vivo theranostics at the peri-infarct region in cerebral ischemia

    Theranostics, Vol. 4, Núm. 1, pp. 90-105

  2. Quick adjustment of imaging tracer payload, for in vivo applications of theranostic nanostructures in the brain

    Nanomedicine: Nanotechnology, Biology, and Medicine, Vol. 10, Núm. 4, pp. 851-858

  3. Regulatory T cells modulate inflammation and reduce infarct volume in experimental brain ischaemia

    Journal of Cellular and Molecular Medicine, Vol. 18, Núm. 8, pp. 1571-1579

2012

  1. Glutamate Excitoxicity Is the Key Molecular Mechanism Which Is Influenced by Body Temperature during the Acute Phase of Brain Stroke

    PLoS ONE, Vol. 7, Núm. 8

  2. Neuroprotection or increased brain damage mediated by temperature in stroke is time dependent

    PLoS ONE, Vol. 7, Núm. 2

2011

  1. The human Tp53 Arg72Pro polymorphism explains different functional prognosis in stroke

    Journal of Experimental Medicine, Vol. 208, Núm. 3, pp. 429-437

2008

  1. Rapid evolving RNA gene HAR1A and schizophrenia

    Schizophrenia Research